Self-administration of cocaine-heroin combinations by rhesus monkeys: Antagonism by naltrexone

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 61-69

  Rowlett, James K ^a,b   Wilcox, Kristin M ^a   Woolverton, William L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; NALTREXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELF ADMINISTRATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; HEROIN; MACACA MULATTA; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION;

EID: 0031870781     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
2. Bain GT and Kornetsky C (1987) Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci 40:1119-1125.
3. Battjes RJ, Pickens RW, Haverkos HW and Sloboda Z (1994) HIV risk factors among injecting drug users in five US cities. AIDS 8:681-687.
4. 2 analysis. J Pharmacol Exp Ther 251:455-460.
5. Broadbent J, Gaspard TM and Dworkin SI (1995) Assessment of the discriminative stimulus effects of cocaine in the rat: Lack of interaction with opioids. Pharmacol Biochem Behav 51:379-385.
6. Brooner RK, King VL, Kidorf M, Schmidt CW and Bigelow GE (1997) Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiat 54:71-80.
7. Brown EE, Finlay JM, Wong JTF, Damsma G and Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: Implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256:119-126.
8. Corrigall WA and Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170.
9. Darke S and Hall W (1995) Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 39:231-235.
10. Depoortere RY, Li DH, Lane JD and Emmett-Oglesby MW (1993) Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 45:539-548.
11. De Vry J, Donselaar I and Van Ree JM (1989) Food deprivation and acquisition of intravenous cocaine self-administration in rats: Effect of naltrexone and haloperidol. J Pharmacol Exp Ther 251:735-740.
12. Ettenberg A, Petit HO, Bloom FE and Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology 78:204-209.
13. Foltin RW and Fischman MW (1992) The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 261:623-632.
14. France CP, DeCosta BR, Jacobson AE, Rice KC and Woods JH (1990) Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. J Pharmacol Exp Ther 252:600-604.
15. Frank B and Galea J (1996) Cocaine trends and other drug trends in New York City, 1986-1994. J Addict Dis 15:1-12.
16. Gerak LR and France CP (1996) Discriminative stimulus effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 276:523-531.
17. Gerak LR, Butelman ER, Woods JH and France CP (1994) Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 271:993-999.
18. Harrigan SE and Downs DA (1978) Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys. J Pharmacol Exp Ther 204:481-486.
19. Hemby SE, Smith JE and Dworkin SI (1996) The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther 277:1247-1258.
20. Houdi AA, Bardo MT and Van Loon GR (1989) Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 497:195-198.
21. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L and Simon EJ (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 3(Suppl I):773-776.
22. Killian AK, Bonese K and Schuster CR (1978) The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug Alcohol Depend 3:243-251.
23. Kimmel HL and Holtzman SG (1997) Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat. J Pharmacol Exp Ther 282: 734-746.
24. Mattox AJ, Thompson SS and Carroll ME (1997) Smoked heroin and cocaine base (speedball) combinations in rhesus monkeys. Exp Clin Psychopharmacol 5:113-118.
25. Meandzija B, O'Conner PG, Fitzgerald B, Rounsaville BJ and Kosten TR (1994) HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend 36:109-113.
26. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
27. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW and Drieze J (1995) A primate model of polydrug abuse: Cocaine and heroin combinations. J Pharmacol Exp Ther 274:1325-1337.
28. Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD and Porreca F (1992) Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole. Eur J Pharmacol 219:345-346.
29. Negus SS, Burke TF, Medzihradsky F and Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903.
30. Office of National Drug Control Policy Pulse Check; National Trends in Drug Abuse, Fall-Spring, 1996 (1997) Office of Drug Control Policy, Rockville, MD.
31. Rady JJ, Baemmert D, Takemori AE, Portoghese PS and Fujimoto JM (1997) Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster Mice. Pharmacol Biochem Behav 56:243-249.
32. Rowlett JK, Massey BW, Kleven MS and Woolverton WL (1996) Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 125:361-370.
33. Rowlett JK and Spealman RD (in press) Opioid enhancement of the discriminative stimulus effects of cocaine: Evidence for involvement of μ and δ opioid receptors. Psychopharmacology.
34. Rowlett JK and Woolverton WL (1997) Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology 133:363-371.
35. Spealman RD and Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261:607-615.
36. Spealman HD and Bergman J (1994) Opioid modulation of the discriminative stimulus effects of cocaine: Comparison of μ, κ and δ agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol 5:21-31.
37. Suzuki T, Mori T, Fumada M, Misawa M and Nagase H (1994) Attenuation of the discriminative stimulus properties of cocaine by δ-opioid receptor antagonists. Eur J Pharmacol 263:207-211.
38. Suzuki T, Mori T, Minoru T, Maeda J, Kishimoto Y, Misawa M and Nagase H (1997) Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur J Pharmacol 324:21-29.
39. 2 and receptor differentiation: A statistical analysis of competitive antagonism. Life Sci 25:637-654.
40. Tutton CS and Crayton JW (1993) Current pharmacotherapies for cocaine abuse: a review J Addict Diseases 12:109-127.
41. Walsh SH, Sullivan JT, Preston KL, Garner JE and Bigelow GE (1996) Effects of naltrexone on responses to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279:524-538.
42. Winger G, Skjoldager P and Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317.